BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18839283)

  • 21. Triggered release in lipid bilayer-capped mesoporous silica nanoparticles containing SPION using an alternating magnetic field.
    Bringas E; Köysüren Ö; Quach DV; Mahmoudi M; Aznar E; Roehling JD; Marcos MD; Martínez-Máñez R; Stroeve P
    Chem Commun (Camb); 2012 Jun; 48(45):5647-9. PubMed ID: 22543447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices.
    Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E
    Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inclusion and release of fenbufen in mesoporous silica.
    Carriazo D; del Arco M; Fernández A; Martín C; Rives V
    J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fabrication of mesoporous SiO(2)-C-Fe(3)O(4)/gamma-Fe(2)O(3) and SiO(2)-C-Fe magnetic composites.
    Sevilla M; Valdés-Solís T; Tartaj P; Fuertes AB
    J Colloid Interface Sci; 2009 Dec; 340(2):230-6. PubMed ID: 19781711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of drug release through the in situ assembly of stimuli-responsive ordered mesoporous silica with magnetic particles.
    Zhu S; Zhou Z; Zhang D
    Chemphyschem; 2007 Dec; 8(17):2478-83. PubMed ID: 17952885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix].
    Wu QL; Quan GL; Hong Y; Wu LN; Zeng YM; Li G; Pan X; Wu CB
    Yao Xue Xue Bao; 2015 Apr; 50(4):492-9. PubMed ID: 26223134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control-release microcapsule of famotidine loaded biomimetic synthesized mesoporous silica nanoparticles: Controlled release effect and enhanced stomach adhesion in vitro.
    Li J; Wang H; Yang B; Xu L; Zheng N; Chen H; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():273-7. PubMed ID: 26478311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigations on nanoconfinement of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug targeting.
    Tomoiaga AM; Cioroiu BI; Nica V; Vasile A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():52-9. PubMed ID: 23777792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ordered mesoporous silicates as matrices for controlled release of drugs.
    Ukmar T; Planinšek O
    Acta Pharm; 2010 Dec; 60(4):373-85. PubMed ID: 21169131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained release of heparin on enlarged-pore and functionalized MCM-41.
    Wan MM; Yang JY; Qiu Y; Zhou Y; Guan CX; Hou Q; Lin WG; Zhu JH
    ACS Appl Mater Interfaces; 2012 Aug; 4(8):4113-22. PubMed ID: 22850329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic silica-coated sub-microspheres with immobilized metal ions for the selective removal of bovine hemoglobin from bovine blood.
    Zhang M; Cheng D; He X; Chen L; Zhang Y
    Chem Asian J; 2010 Jun; 5(6):1332-40. PubMed ID: 20397183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
    Park SB; Joo YH; Kim H; Ryu W; Park YI
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and release kinetics study of potato starch nanocomposite films containing mesoporous nano-silica incorporated with Thyme essential oil.
    Cui Y; Cheng M; Han M; Zhang R; Wang X
    Int J Biol Macromol; 2021 Aug; 184():566-573. PubMed ID: 34174300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-responsive mesoporous silica nanocarriers based on layer-by-layer self-assembly.
    Zhang HY; Sun YF; Sun YL; Zhou M
    Biomed Mater Eng; 2014; 24(6):2211-8. PubMed ID: 25226920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel multifunctional nanocomposites: magnetic mesoporous silica nanospheres covalently bonded with near-infrared luminescent lanthanide complexes.
    Feng J; Song SY; Deng RP; Fan WQ; Zhang HJ
    Langmuir; 2010 Mar; 26(5):3596-600. PubMed ID: 19886634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.